Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$20.71 - $35.37 $1.62 Million - $2.77 Million
-78,426 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$16.19 - $29.91 $144,236 - $266,468
-8,909 Reduced 10.2%
78,426 $1.62 Million
Q4 2020

Feb 02, 2021

BUY
$14.99 - $22.75 $109,561 - $166,279
7,309 Added 9.13%
87,335 $1.53 Million
Q3 2020

Nov 05, 2020

BUY
$9.65 - $15.19 $656,200 - $1.03 Million
68,000 Added 565.44%
80,026 $1.19 Million
Q1 2019

May 03, 2019

BUY
$3.45 - $10.35 $41,489 - $124,469
12,026 New
12,026 $59,000

Others Institutions Holding CLDX

About Celldex Therapeutics, Inc.


  • Ticker CLDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,772,400
  • Market Cap $1.26B
  • Description
  • Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...
More about CLDX
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.